| 150 TG INTERACTING FACTOR ACTS AS A TRANSCRIPTIONAL REPRESSOR OF ACAT2 IN HUMAN C Pramfalk, M Eriksson, P Parini Atherosclerosis (Supplements)(Component) 1 (12), 34, 2011 | | 2011 |
| 175 THE INHIBITION OF HEPATIC ACYL COENZYME A: CHOLESTEROL ACYLTRANSFERASE (ACAT) 2 POSITIVELY AFFECTS HDL METABOLISM AND FUNCTIONALITY IN MICE M Pedrelli, P Davoodpour, C Degirolamo, M Gomaraschi, L Larsson, ... Atherosclerosis (Supplements)(Component) 1 (12), 39, 2011 | | 2011 |
| 3P-0783 New molecular effects of cholesterol synthesis inhibition on hepatic cholesterol metabolism in humans M Eriksson, MA Davis, U Gustafsson, MC Willingham, C Einarsson, ... Atherosclerosis (Supplements)(Component) 2 (4), 233, 2003 | | 2003 |
| 444 ROLES OF LXR AND LXR IN THE REGULATION OF INTESINAL CHOLESTEROL ABSORPTION: DISTINCTIVE EFFECTS ON BILE ACID METABOLISM IN MICE X Hu, K Steffensen, ZY Jiang, P Parini, J Gustafsson, M Gfvels, ... Atherosclerosis-Supplements 12 (1), 95, 2011 | | 2011 |
| A functional genetic variant in the lipid droplet-associated protein perilipin 2 (PLIN2) affects cholesterol content and autophagy in human primary macrophages treated with oxLDL E Ehrenborg, P Gustafsson, O Werngren, M Pedrelli, P Parini, J Magné Atherosclerosis 252, e249, 2016 | | 2016 |
| A global network for network medicine BA Maron, L Altucci, JL Balligand, J Baumbach, P Ferdinandy, S Filetti, ... NPJ systems biology and applications 6 (1), 29, 2020 | 22 | 2020 |
| Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout mice [S] K Slätis, M Gåfvels, K Kannisto, O Ovchinnikova, G Paulsson-Berne, ... Journal of lipid research 51 (11), 3289-3298, 2010 | 54 | 2010 |
| ACAT2 and human hepatic cholesterol metabolism: Identification of important gender-related differences ZY Jiang, C Einarsson, G Eggertsen, MA Davis, L Wang, SD Zhang, ... ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 27 (6), E92-E92, 2007 | | 2007 |
| ACAT2 and human hepatic cholesterol metabolism: identification of important gender-related differences in normolipidemic, non-obese Chinese patients P Parini, ZY Jiang, C Einarsson, G Eggertsen, SD Zhang, LL Rudel, ... Atherosclerosis 207 (1), 266-271, 2009 | 31 | 2009 |
| ACAT2 and human hepatic cholesterol mkiabolism: Identification of important gender-related differences ZY Jiang, P Parini, C Einarsson, G Eggertsen, MA Davis, L Wang, ... ATHEROSCLEROSIS SUPPLEMENTS 8 (1), 24-24, 2007 | | 2007 |
| ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia LL Rudel, RG Lee, P Parini Arteriosclerosis, thrombosis, and vascular biology 25 (6), 1112-1118, 2005 | 142 | 2005 |
| ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver P Parini, M Davis, AT Lada, SK Erickson, TL Wright, U Gustafsson, ... Circulation 110 (14), 2017-2023, 2004 | 252 | 2004 |
| Accumulation of foam cells in liver X receptor-deficient mice GU Schuster, P Parini, L Wang, S Alberti, KR Steffensen, GK Hansson, ... Circulation 106 (9), 1147-1153, 2002 | 239 | 2002 |
| Acyl-Coa: Cholesterol acyltransferase 2 and ATP-binding cassette half transporters G5 and G8 differentially alter hepatic lipoprotein secretion and composition HM Alger, P Parini, R Shah, L Yu, LL Rudel ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 27 (6), E57-E57, 2007 | | 2007 |
| Advances in the therapy of cholestatic liver disease E Roda, P Parini, F Bazzoli, G Mazzella, D Festi, R Aldini Hepato-gastroenterology 39, 53-55, 1992 | 3 | 1992 |
| Age-induced hypercholesterolemia in the rat relates to reduced elimination but not increased intestinal absorption of cholesterol C Galman, M Matasconi, L Persson, P Parini, B Angelin, M Rudling American Journal of Physiology-Endocrinology and Metabolism 293 (3), E737-E742, 2007 | 54 | 2007 |
| An Increased Cholesterol Synthesis to Cholesterol Absorption Ratio Is Associated with Coronary Artery Calcification in Treatment-Naive Patients PH Joshi, I Marvasty, R LeStrange, G Vazquez, S Silas, N Flockhart, ... ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 30 (11), E248-E248, 2010 | | 2010 |
| and normocholesterolemic subjects H Bergstrom, B Angelin, P Parini | | |
| Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice E Brakenhielm, R Cao, B Gao, B Angelin, B Cannon, P Parini, Y Cao Circulation research 94 (12), 1579-1588, 2004 | 418 | 2004 |
| Athero-protective properties of plasma lipoproteins from brown bears (URSUS ARCTOS) during hibernation and active state M Pedrelli, P Parini, J Kindberg, JM Arnemo, I Björkhem, U Aasa, ... Atherosclerosis 315, e69-e70, 2020 | | 2020 |
